AFRM vs BVS · P/E 590, rev $3.22B vs rev $573.3M
Affirm Holdings Inc (AFRM) versus Bioventus Inc (BVS) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Bioventus Inc (BVS) is a medical devices company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. BVS currently screens at market cap $495.1M.
Not investment advice. Open the AFRM and BVS stock pages for the full models.
Not investment advice.